Drug Trial Radar · NCT04231968
A Study of AK0529 in Chinese Infants Hospitalized With RSV
Last checked: Nov 20, 2026Latest source record: Feb 13, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
311
Actual
Start
Sep 22, 2020
Primary completion
Jan 21, 2022
Study completion Feb 2, 2022
Sponsor
- Lead sponsor
- Shanghai Ark Biopharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jan 18, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 1 month, up to 24 months
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, double-blind, placebo-controlled, multicenter, phase III study to be conducted in infants hospitalized with RSV infection in China. The main objectives of this study are to investigate the efficacy and safety of AK0529 in Chinese infants.
Conditions
- Respiratory Syncytial Virus Infections
Interventions
AK0529Drug
AK0529 capsule will be orally administered at the twice-daily dosing levels of 10 mg, 20 mg, or 40 mg for five days based on the patient's weight.
Matching placebo of AK0529Drug
The placebo capsule was made with the same smell and appearance as AK0529 but without the active ingredients and will be orally administered per the same treatment schedule as those in the experimental arm.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinically significant change from baseline in bronchiolitis score on Day 3Time frame: From Baseline (Pre-dose on Day 1) to Day 3 (48 hours)
Locations
28 sites in 1 country. Site status is shown where the registry gives one.
Beijing Children's Hospital
Beijing, China
Peking University Third Hospital
Beijing, China
The First Bethune Hospital of Jilin University
Changchun, China
Hunan Provincial People's Hospital
Changsha, China
West China Women's and Children's Hospital
Chengdu, China
Children's Hospital of Chongqing Medical University
Chongqing, China
Guangzhou Women and Children's Medical Center
Guangzhou, China
The Children's Hospital of Zhejiang University School of Medicine
Hangzhou, China
Liaocheng People's Hospital
Liaocheng, China
Jiangxi Provincial Children's Hospital
Nanchang, China
Children's Hospital of Nanjing Medical University
Nanjing, China
Jiangsu Province Hospital
Nanjing, China
The First Affiliated Hospital of Guangxi Medical University
Nanjing, China
Hainan Third People's Hospital
Sanya, China
Children's Hospital of Shanghai
Shanghai, China
Shanghai Children's Medical Center
Shanghai, China
Shengjing Hospital of China Medical University
Shengyang, China
Shenzhen Children's Hospital
Shenzhen, China
Children's Hospital of Soochow University
Suzhou, China
Tianjin Children's Hospital
Tianjin, China
The Second Affiliated Hospital and Yuying Children's Hospital of WMU
Wenzhou, China
Wuhan Children's Hospital
Wuhan, China
Wuxi Children's Hospital
Wuxi, China
The First Affiliated Hospital of Xiamen University
Xiamen, China
Xiamen Maternity and Child Healthcare Hospital
Xiamen, China
Henan Children's Hospital
Zhengzhou, China
The Third Affiliated Hospital of Zhengzhou University
Zhengzhou, China
Boai Hospital of Zhongshan
Zhongshan, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.